PMID-sentid	Pub_year	Sent_text		comp_official_name	comp_offsetprotein_name	organism	prot_offset
33123485-6	2020	After a 3-week treatment, the mifepristone/temozolomide regimen had decreased the level of VEGF and P-gp and significantly reduced tumor proliferation (detected by PET/CT images based on 18F-fluorothymidine uptake).	Temozolomide	43-55	ATP binding cassette subfamily B member 1	Homo sapiens	100-104	
33123485-9	2020	After the mifepristone/temozolomide treatment ended, however, the values of VEGF, P-gp, and MGMT increased and reached control levels by 14 weeks post-treatment.	Temozolomide	23-35	ATP binding cassette subfamily B member 1	Homo sapiens	82-86